For the first time, the U.S.
Brazilian indigenous spiritual leader, Chief iIxiwaka Biraci Yawanawa, will be giving a keynote address on June 23 on the ‘Importance of Protecting Ayahuasca Biocultures From Commercialization,...
Global investment firm Psych Capital has agreed to acquire 100% of the issued share capital of Shortwave Pharma Inc.,
A new Ethics Council was launched at the Inaugural Summit of The World’s Leaders in Psychedelics that will work to guide industry standards and best practices.
PSYCH Symposium: London 2023 is returning on 6 July at the iconic British Museum to explore the latest challenges and opportunities in the field of psychedelic...
With a rise in clinical research and trials into the use of psychedelic therapies for mental health, and with a number of countries changing regulations around...
The world’s first postgraduate course on psychedelics has been launched at the University of Exeter – an interdisciplinary programme for healthcare workers, therapists and others to...
Filament Health and PharmAla Biotech Holdings Inc.
With a high demand for psychedelic facilitators, Cybin Inc.
With years of experience in developing cannabinoid medicines, Australia-based MGC Pharmaceuticals will now be branching into psychedelic medicine development.
